Pages that link to "Q34720361"

The following pages link to Pulmonary and systemic vasodilator responses to the soluble guanylyl cyclase activator, BAY 60-2770, are not dependent on endogenous nitric oxide or reduced heme (Q34720361):

Displaying 30 items.

• Insights into BAY 60-2770 Activation and S -Nitrosylation-Dependent Desensitization of Soluble Guanylyl Cyclase via Crystal Structures of Homologous Nostoc H-NOX Domain Complexes (Q27677544) (← links)
• Oxidative stress associated with middle aging leads to sympathetic hyperactivity and downregulation of soluble guanylyl cyclase in corpus cavernosum (Q28247831) (← links)
• Environmentally persistent free radicals decrease cardiac function and increase pulmonary artery pressure (Q28391873) (← links)
• Vasodilator responses to acetylcholine are not mediated by the activation of soluble guanylate cyclase or TRPV4 channels in the rat. (Q33701956) (← links)
• Targeting soluble guanylate cyclase for the treatment of pulmonary hypertension. (Q34179857) (← links)
• Pressure-overload-induced subcellular relocalization/oxidation of soluble guanylyl cyclase in the heart modulates enzyme stimulation (Q34686759) (← links)
• Soluble guanylate cyclase as an emerging therapeutic target in cardiopulmonary disease (Q35010064) (← links)
• Soluble guanylate cyclase: a new therapeutic target for pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension (Q35075847) (← links)
• Pathophysiology of hypertension in the absence of nitric oxide/cyclic GMP signaling (Q36532454) (← links)
• The sGC activator BAY 60-2770 has potent erectile activity in the rat. (Q36923923) (← links)
• Imatinib attenuates monocrotaline pulmonary hypertension and has potent vasodilator activity in pulmonary and systemic vascular beds in the rat. (Q37342077) (← links)
• Pediatric pulmonary arterial hypertension: current and emerging therapeutic options (Q37879213) (← links)
• IRAG and novel PKG targeting in the cardiovascular system (Q37888340) (← links)
• Stimulators and activators of soluble guanylate cyclase: review and potential therapeutic indications. (Q38000562) (← links)
• Modulation of soluble guanylate cyclase for the treatment of erectile dysfunction (Q38118626) (← links)
• Activation of haem-oxidized soluble guanylyl cyclase with BAY 60-2770 in human platelets lead to overstimulation of the cyclic GMP signaling pathway (Q41329824) (← links)
• Analysis of erectile responses to imatinib in the rat. (Q41832111) (← links)
• Soluble guanylyl cyclase-activated cyclic GMP-dependent protein kinase inhibits arterial smooth muscle cell migration independent of VASP-serine 239 phosphorylation (Q41869044) (← links)
• Direct sGC activation bypasses NO scavenging reactions of intravascular free oxy-hemoglobin and limits vasoconstriction (Q41894813) (← links)
• Endothelin-1 and endothelin-2 initiate and maintain contractile responses by different mechanisms in rat mesenteric and cerebral arteries (Q41974344) (← links)
• Analysis of responses to glyceryl trinitrate and sodium nitrite in the intact chest rat. (Q42502151) (← links)
• The selective Rho-kinase inhibitor azaindole-1 has long-lasting erectile activity in the rat. (Q43160649) (← links)
• The Rho kinase inhibitor azaindole-1 has long-acting vasodilator activity in the pulmonary vascular bed of the intact chest rat. (Q43957399) (← links)
• Activation of soluble guanylyl cyclase by BAY 58-2667 improves bladder function in cyclophosphamide-induced cystitis in mice. (Q46556756) (← links)
• Search for an animal model to investigate selective pulmonary vasodilation (Q47360550) (← links)
• Peroxynitrite has potent pulmonary vasodilator activity in the rat. (Q47977733) (← links)
• Vascular dysfunctions in the isolated aorta of double-transgenic hypertensive mice developing aortic aneurysm. (Q54185546) (← links)
• The soluble guanylyl cyclase activator BAY 60-2770 potently relaxes the pulmonary artery on congenital diaphragmatic hernia rabbit model (Q87445917) (← links)
• Redox regulation of soluble guanylyl cyclase (Q88171942) (← links)
• Emerging antenatal therapies for congenital diaphragmatic hernia-induced pulmonary hypertension in preclinical models (Q100514533) (← links)